Nuclear type II [3H]estradiol binding sites: A histone H3-H4 complex

Journal of Steroid Biochemistry and Molecular Biology

Volumn 96, Issue 1, 2005, Pages 19-30

  Shoulars, Kevin ^a   Rodrigues, Mary Ann ^a   Crowley, Jan R ^b   Turk, John ^b   Thompson, Trellis ^a   Markaverich, Barry M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3H estradiol; H3 H4 complex; Histone; Type II binding sites

Indexed keywords

BIOFLAVONOID; DIMER; ESTRADIOL; HISTONE; HISTONE H3; HISTONE H4; LUTEOLIN; PHYTOESTROGEN; TRITIUM;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CATTLE; CELL NUCLEUS; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HORMONE BINDING; ISOTOPE LABELING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOSOME; PROTEIN ANALYSIS; PROTEIN PURIFICATION; RAT; THYMUS; UTERUS;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; FEMALE; HISTONES; HUMANS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; UTERUS;

EID: 23144442858     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.12.047     Document Type: Article

References (27)

1. L. Chang, S. Loranger, C. Mizzen, S.G. Ernst, D. Allis, and A.T. Annunziato Histones in transit: cytosolic histone complexes and diacetylation of H4 during nucleosome assembly in human cells Biochemistry 36 1997 469 480
2. D. Edmondson, and S. Roth Chromatin and transcription FASEB J. 10 1996 1173 1182
3. H. Eriksson, S. Upchurch, J.W. Hardin, E.J. Peck Jr., and J.H. Clark Heterogeneity of estrogen receptors in the cytosol and nuclear fractions of the rat uterus Biochem. Biophys. Res. Commun. 81 1978 1 7
4. L.A. Griffiths, and G.E. Smith Metabolism of apigenin and related compounds in the rat Biochem. J. 128 1972 901 911
5. M. Iizuka, M.M.Smith, Functional consequences of histone modifications, Curr. Opin. Genet. Dev. 13 (2003) 154-160.
6. P. Lewis, E.M. Bradbury, and C. Crane-Robinson Ionic strength induced structure in histone H4 and its fragments Biochemistry 14 1975 3391 3400
7. R. Lewis, D.J. Cox, and G.R. Reeck Chromatographic change in histone H3-H4 preparations during short term storage and its reversal by bisulfite Int. J. Pept. Protein Res. 16 1980 219 224
8. Z. Liu, S. Tsai, M.-J. Tsai, and B. O'Malley Steroid receptor coactivator (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin Proc. Natl. Acad. Sci. U.S.A. 96 1999 9485 9490
9. B. Markaverich, and R. Gregory Preliminary assessment of luteolin as an affinity ligand for type II estrogen binding sites in rat uterine nuclear extracts Steroids 58 1993 268 274
10. 3H]luteolin Steroids 66 2001 707 719
11. 3H]estradiol binding sites and prostatic cancer cell proliferation Int. J. Oncol. 11 1998 1311 1319
12. B.M. Markaverich, and J.H. Clark Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response Endocrinology 105 1979 1458 1462
13. B.M. Markaverich, and R.R. Gregory Preliminary characterization and partial purification of rat uterine nuclear type II sites Biochem. Biophys. Res. Commun. 177 1991 1283 1290
14. 3H]dopamine binding sites in normal and malignant cells: relationship to cell proliferation Biochem. Biophys. Res. Commun. 165 1989 391 400
15. B.M. Markaverich, R.R. Gregory, M.A. Alejandro, J.H. Clark, G.A. Johnson, and B.S. Middleditch Methyl p-hydroxyphenyllactate: an inhibitor of cell proliferation and an endogenous ligand for nuclear type II binding sites J. Biol. Chem. 263 1988 7203 7210
16. B.M. Markaverich, T.H. Schauweker, R.R. Gregory, M. Varma, F.S. Kittrell, D. Medina, and R.S. Varma Nuclear type II sites and malignant cell proliferation: inhibition by benzylidenecyclohexanones Cancer Res. 52 1992 2482 2488
17. 3H]estradiol binding sites in MCF-7 human breast cancer cells: binding interactions with 2,6-bis([3,4-dihydroxyphenyl]- methylene)-cyclohexanone esters and inhibition of cell proliferation Int. J. Oncol. 4 1994 1291 1300
18. C. Mizzen, and C. Allis Linking histone acetylation to transcriptional regulation Cell. Mol. Life Sci. 54 1998 6 20
19. C. Perry, C. Dadd, D. Allis, and A. Annunziato Analysis of nucleosome assembly and histone exchange using antibodies specific for acetylate H4 Biochemistry 32 1993 13605 13614
20. M. Piantelli, N. Maggiano, R. Ricci, L.M. Larocca, A. Capelli, G. Scambia, G. Iola, P.G. Natali, and F.O. Ranelletti Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells J. Invest. Dermatol. 105 1995 248 253
21. M. Piantelli, R. Ricci, L. Larocca, A. Capelli, S. Rizzo, G. Scambia, and F. Ranelletti Type II estrogen binding sites in human colorectal carcinoma J. Clin. Pathol. 43 1990 1004 1006
22. M. Piantelli, A. Rinelli, E. Macri, N. Maggiano, L. Larocca, M. Scerrati, R. Roselli, M. Iacoangeli, G. Scambia, and A. Capelli Type II estrogen binding sites and antiproliferative activity of quercetin in human menigiomas Cancer 71 1993 193 198
23. M. Santisteban, G. Arents, N. Moudrianakis, and M. Smith Histone octamer function in vivo: mutation in the dimmer-tetramer interfaces disrupt both gene activation and repression EMBO J. 16 1997 2493 2506
24. 3H]estradiol binding sites as histone H4 Biochem. Biophys. Res. Commun. 296 2002 1083 1090
25. K. Tikoo, S. Lau, and T. Monks Histone H3 phosphorylation is coupled to poly-(adp-ribosylation) during reactive oxygen species-induced cell death in renal proximal tubular epithelial cells Mol. Pharmacol. 60 2001 394 402
26. A. Wolffe, and D. Guschin Review: chromtin structural features and targets that regulate transcription J. Struct. Biol. 129 2000 102 122
27. J. Wu, and M. Grunstein 25 years after the nucleosome model: chromatin modification Trends Biochem. Sci. 25 2000 619 629